Maraviroc | B2044

Maraviroc is a potent and selective C-C chemokine receptor type 5 (CCR5) antagonist drug that is designed to act against HIV by interfering with the interaction between HIV and CCR5.

Maraviroc is a potent and selective C-C chemokine receptor type 5 (CCR5) antagonist drug that is designed to act against HIV by interfering with the interaction between HIV and CCR5.

B2044 | Maraviroc DataSheet

Alternate Name/Synonyms: 4,4-difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]-cyclohexanecarboxamide; UK427857; MVC

Appearance: White solid

Formulation: N/A

CAS Number: 376348-65-1

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₂₉H₄₁F₂N₅O

Molecular Weight: 513.67

Cell-Permeable?: Yes

Purity: ≥98% by HPLC

Solubilities: DMSO (>30 mg/ml)

Handling: Protect from air and light

Country of Origin: USA

Tag Line: A potent and selective C-C chemokine receptor type 5 (CCR5) antagonist

MDL Number: MFCD13188530

PubChem CID: 3002977

SMILES: CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C

InChi: InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1

InChi Key: GSNHKUDZZFZSJB-HLMSNRGBSA-N